The pharmaceutical industry is anxiously awaiting a series of regulatory actions from the Obama administration aimed at combating high drug prices.
Drug prices have been a major issue on the campaign trail, with Hillary Clinton, Bernie Sanders and Donald Trump pounding pharmaceutical companies.
Read Full Article »